Results 71 to 80 of about 12,165 (179)
PM patients exhibit distinctions from IPA in certain clinical characteristics, laboratory parameters, and chest radiology findings. Nevertheless, both PM and IPA patients experienced higher 30‐day mortality and ICU utilization. The combination of NLR and HbA1c with existing disease assessment tools proves effective in prognosticating the disease ...
Yu Bai +5 more
wiley +1 more source
Mucormycosis encompasses a range of fungal infections that can impact various organs. Although pulmonary mucormycosis is relatively rare, it poses a significant threat, particularly to individuals with compromised immune systems. Pulmonary mucormycosis
Hyo Ju Na +4 more
doaj +1 more source
Mucormycosis in patients with diabetes mellitus in Russia: registry data analysis
We observed 100 patients with mucormycosis from 2002 to 2024. We used the EORTC/MSGERC 2019, 2020 criteria for diagnosing mucormycosis. Mucormycosis developed against the background of type 2 diabetes mellitus in 10% of patients, type 1 in 7%, in 83 ...
S. N. Khostelidi +9 more
doaj +1 more source
ACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Leonardo Rodrigues Campos +6 more
wiley +1 more source
Cutaneous mucormycosis in advanced HIV disease
Angionvasive mucormycosis is an emerging fungal disease known to affect mainly diabetics or subjects with profound neutropenia. Infection usually occurs through the inhalation route, but cutaneous inoculation may occur after trauma or burns.
José Moreira +4 more
doaj +1 more source
Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study
Introduction: Mucormycosis, a rare but serious fungal infection, surged during the second wave of the COVID-19 pandemic. Despite various proposed causative factors, published data are limited.
Akkilagunta Sujiv +5 more
doaj +1 more source
Emergence of mucormycosis in post-COVID infections in tertiary care hospital Warangal
Introduction: Mucormycosis is an emerging fungal infection associated with high mortality, especially in post-COVID state. Mucormycosis, though fungal spores ubiquitous in the environment, is a clinical disease that occurs in immunocompromised conditions.
Goteti V. Padmaja, Shanigarapu R. Kumar
doaj +1 more source

